Skip to main content
Clinical Trials/NCT02315560
NCT02315560
Completed
N/A

Foot Neuromodulation for Nocturnal Enuresis in Children

Heidi Stephany1 site in 1 country25 target enrollmentSeptember 2014
ConditionsBedwetting

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bedwetting
Sponsor
Heidi Stephany
Enrollment
25
Locations
1
Primary Endpoint
Decrease in Nocturnal Enuresis
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

To determine the effects of electrical stimulation of the nerves in the foot on the incidence of nocturnal enuresis (bedwetting) in children

Detailed Description

Nocturnal Enuresis is a very common and difficult to treat problem in the pediatric population which can have significant negative impact on a child's quality of life. Apart from medications which can have significant side effects limiting their use, there is a lack of effective and safe treatment options for children with frequent nocturnal enuresis. If foot stimulation prior to bed does indeed improve the frequency of nocturnal enuresis, it may provide a safe and non-invasive therapeutic option.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
April 6, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Heidi Stephany
Responsible Party
Sponsor Investigator
Principal Investigator

Heidi Stephany

Assistant Professor

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Children ages 5 to 16 years old without any specific neurological disorder or urinary tract infection, clinically diagnosed as having nocturnal enuresis AT LEAST 4 episodes per month by history
  • Currently having no daytime overactive bladder symptoms, i.e. urinary frequency, urgency, or daytime incontinence
  • Having been assessed for and treated if applicable for behavioral etiologies of nocturnal enuresis - consuming excess fluids or specific bladder irritants
  • Having been assessed for and treated if applicable for constipation

Exclusion Criteria

  • Children with known neurological disorders which may be contributing to nocturnal enuresis episodes
  • Children found through history to have significant behavioral causes of nocturnal enuresis including consumption of excessive fluids or known bladder irritants
  • Children with chronic constipation who are non-compliant with previous pharmacologic efforts to treat.
  • Children who are not adequately potty trained
  • Children with significant daytime symptoms of overactive bladder including frequency, urgency, and daytime incontinence
  • Children who do not tolerate initial stimulation training session in the urology clinic upon enrollment
  • Children with any implantable medical devices such as a pacemaker will be excluded from the study
  • Note: Any patient currently taking medication such as an anti-muscarinic or a tricyclic antidepressant for overactive bladder at time of enrollment will be eligible to participate and will be continued on their usual medication and dosage throughout the study.

Outcomes

Primary Outcomes

Decrease in Nocturnal Enuresis

Time Frame: 6 weeks

To determine if foot stimulation can decrease nocturnal enuresis in children as measured by daily night-time voiding log. The outcome is the number of participants that had a clinical response with improvement of at least 1 wet night reduction during the 6-week stimulation period.

Secondary Outcomes

  • Quality of Life Questionnaire Scores(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials